In rodents, Nrg4 inhibits de novo hepatic lipogenesis which in turn suppresses the progression of NAFLD to non-alcoholic steatohepatitis [24]. The gene discussed is NRG4; the disease is metabolic dysfunction-associated steatotic liver disease.